Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Orphazyme presents 36-month data supporting durable response to arimoclomol during Parseghian .
ORPHAZYME A/SJune 28, 2021 GMT
Orphazyme A/S Company Registration No. 32266355
Copenhagen – June 28, 2021 – Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical company, today announced 24-month interim results of an open-label extension (OLE) trial, providing efficacy and safety data for its investigational treatment arimoclomol in Niemann-Pick disease type C (NPC) for up to 36 months. The data are featured in a presentation as part of the Parseghian Scientific Conference for Niemann-Pick disease type C Research.
Orphazyme presents 36-month data supporting durable response to arimoclomol during Parseghian Scientific Conference for NPC Research
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
3 Minnesota hospitals recognized on list of best children s hospitals
kstp.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kstp.com Daily Mail and Mail on Sunday newspapers.
KAAL-TV Created: June 15, 2021 02:42 PM
(ABC 6 News) - Mayo Clinic Children s Center is ranked as a top-performing children s hospital on U.S. News & World Report s 2021–2022 Best Children s Hospitals rankings. Mayo Clinic Children s Center receives some of the highest rankings in the upper Midwest and continues to rank among the top children s hospitals in the country. These recognitions are a testament to our staff s delivery of high-quality care and services, says Randall Flick, M.D., medical director of Mayo Clinic Children s Center. From prenatal patients to those transitioning into adulthood, Mayo Clinic Children s Center strives to improve the quality of life to children of all ages, abilities and health challenges.